《优化老年共病患者多重用药和处方精简策略》解读  

Interpretation of the optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy

作　　者：郭浩 张文静 黄格日勒 杨宏昕 赵科 Guo Hao;Zhang Wenjing;Huang Gerile;Yang Hongxin;Zhao Ke(Department of Pharmacy,Inner Mongolia Autonomous Region People′s Hospital,Hohhot 010017,China)

机构地区：[1]内蒙古自治区人民医院药学处,呼和浩特010017

出　　处：《中华老年医学杂志》2025年第2期130-135,共6页Chinese Journal of Geriatrics

摘　　要：不适当多重用药在老年共病患者中较为常见,医务人员对多重用药的老年共病患者进行处方精简有助于保障老年患者用药安全。2023年欧洲老年医学会联盟通过汇总老年人用药审查和处方精简文献,提出优化老年共病患者多重用药和处方精简33条推荐意见。该策略建议将处方精简纳入老年科医生和临床药师的日常诊疗工作当中,并且在临床医务人员教育培训、疾病诊疗指南制定、政策支持以及临床试验研究等多个方面提出推荐意见,旨在加强老年人多重用药管理。本文对该策略重点内容进行解读,以期为我国老年共病患者提供高质量医疗保健工作提供参考。Inappropriate polypharmacy is common in older patients with co-morbidities,and prescription streamlining can help to ensure the safety of medications for older patients with co-morbidities.In 2023,The Alliance of European Geriatrics Societies(AEGS)summarized the literature on medication review and prescription streamlining to propose 33 recommendations for optimizing polypharmacy and prescription streamlining in older patients with co-morbidities.The strategy suggests incorporating prescription streamlining into the daily practice of geriatricians and clinical pharmacists,and provides recommendations about education and training of clinical staff,development of disease guidelines,policy support,and clinical trial research in older adults aiming to improve the management of polypharmacy.This article explains the key elements of this strategy to provide reference for high-quality healthcare for elderly patients with co-morbid in China.

关 键 词：多种药物疗法 共病现象 处方集 

分 类 号：R95[医药卫生—药学]